WallStreetZenWallStreetZen

NASDAQ: XCUR
Exicure Inc Stock

$0.74+0.03 (+4.23%)
Updated Mar 1, 2024
XCUR Price
$0.74
Fair Value Price
N/A
Market Cap
$6.43M
52 Week Low
$0.37
52 Week High
$1.50
P/E
0.44x
P/B
0.66x
P/S
0.46x
PEG
N/A
Dividend Yield
N/A
Revenue
$23.79M
Earnings
$3.07M
Gross Margin
100%
Operating Margin
13.76%
Profit Margin
12.9%
Debt to Equity
0.81
Operating Cash Flow
-$22M
Beta
0.9
Next Earnings
Mar 25, 2024
Ex-Dividend
N/A
Next Dividend
N/A

XCUR Overview

Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease and Angelman syndrome. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how XCUR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

XCUR was unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
XCUR is good value based on its earnings relative to its share price (0.44x), compared to the US market average (36.17x)
P/E vs Market Valuation
XCUR is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more XCUR due diligence checks available for Premium users.

Be the first to know about important XCUR news, forecast changes, insider trades & much more!

XCUR News

Valuation

XCUR price to earnings (PE)

For valuing profitable companies with steady earnings
Company
0.44x
Industry
15.19x
Market
36.17x
XCUR is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
XCUR is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

XCUR price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.66x
Industry
6.18x
XCUR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

XCUR's financial health

Profit margin

Revenue
$0.0
Net Income
-$5.8M
Profit Margin
0%
XCUR's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
XCUR's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$17.6M
Liabilities
$7.9M
Debt to equity
0.81
XCUR's short-term assets ($3.66M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
XCUR's long-term liabilities ($6.42M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
XCUR's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
XCUR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$4.8M
Investing
-$1.9M
Financing
-$919.0k
XCUR's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

XCUR vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
XCUR$6.43M+4.79%0.44x0.66x
ALZN$6.54M+0.22%-0.38x-2.44x
XRTX$6.54M+7.70%-1.06x1.48x
NEXI$6.55M-7.61%-0.15x0.79x
LIPO$6.56M+0.96%-1.36x2.09x

Exicure Stock FAQ

What is Exicure's quote symbol?

(NASDAQ: XCUR) Exicure trades on the NASDAQ under the ticker symbol XCUR. Exicure stock quotes can also be displayed as NASDAQ: XCUR.

If you're new to stock investing, here's how to buy Exicure stock.

What is the 52 week high and low for Exicure (NASDAQ: XCUR)?

(NASDAQ: XCUR) Exicure's 52-week high was $1.50, and its 52-week low was $0.37. It is currently -50.4% from its 52-week high and 103.84% from its 52-week low.

How much is Exicure stock worth today?

(NASDAQ: XCUR) Exicure currently has 8,648,307 outstanding shares. With Exicure stock trading at $0.74 per share, the total value of Exicure stock (market capitalization) is $6.43M.

Exicure stock was originally listed at a price of $93.00 in May 22, 2018. If you had invested in Exicure stock at $93.00, your return over the last 5 years would have been -99.2%, for an annualized return of -61.93% (not including any dividends or dividend reinvestments).

How much is Exicure's stock price per share?

(NASDAQ: XCUR) Exicure stock price per share is $0.74 today (as of Mar 1, 2024).

What is Exicure's Market Cap?

(NASDAQ: XCUR) Exicure's market cap is $6.43M, as of Mar 3, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Exicure's market cap is calculated by multiplying XCUR's current stock price of $0.74 by XCUR's total outstanding shares of 8,648,307.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.